Multiple DICER1‐related tumors in a child with a large interstitial 14q32 deletion

• Published in: Genes chromosomes & cancer Vol. 57; no. 5; pp. 223 - 230
• Main Authors: de Kock, Leanne, Geoffrion, Dominique, Rivera, Barbara, Wagener, Rabea, Sabbaghian, Nelly, Bens, Susanne, Ellezam, Benjamin, Bouron‐Dal Soglio, Dorothée, Ordóñez, Jessica, Sacharow, Stephanie, Polo Nieto, Jose Fernando, Guillerman, R. Paul, Vujanic, Gordan M., Priest, John R., Siebert, Reiner, Foulkes, William D.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01-05-2018
• Subjects: Children; Chromosome 14; Chromosome deletion; Clonal deletion; Copy number; Cysts; Gene deletion; Genetic analysis; Lungs; Mutation; p53 Protein; Ribonuclease; Sarcoma; Tumors
• ISSN: 1045-2257; 1098-2264
• DOI: 10.1002/gcc.22523

Germ‐line interstitial deletions involving the 14q32 chromosomal region, resulting in 14q32 deletion syndrome, are rare. DICER1 is a recently described cancer‐predisposition gene located at 14q32.13. We report the case of a male child with a ∼5.8 Mbp 14q32.13q32.2 germ‐line deletion, which included the full DICER1 locus. We reviewed available clinical and pathological material, and conducted genetic analyses. In addition to having congenital dysmorphic features, the child developed multiple DICER1 syndrome‐related tumors before age 5 y: a pediatric cystic nephroma (pCN), a ciliary body medulloepithelioma (CBME), and a small lung cyst (consistent with occult pleuropulmonary blastoma Type I/Ir cysts seen in DICER1 mutation carriers). He also developed a cerebral spindle‐cell sarcoma with myogenous differentiation. Our investigations revealed that the deletion encompassed 31 protein‐coding genes. In addition to the germ‐line DICER1 deletion, somatic DICER1 RNase IIIb mutations were found in the CBME (c.5437G > A, p.E1813K), pCN (c.5425G > A, p.G1809R), and sarcoma (c.5125G > A, p.D1709N). The sarcoma also harbored a somatic TP53 mutation: c.844C > T, p.R282W. Additional copy number alterations were identified in the CBME and sarcoma using an OncoScan array. Among the 8 cases with molecularly‐defined 14q32 deletions involving DICER1 and for whom phenotypic information is available, our patient and one other developed DICER1‐related tumors. Biallelic DICER1 mutations have not previously been reported to cause cerebral sarcoma, which now may be considered a rare manifestation of the DICER1 syndrome. Our study shows that DICER1‐related tumors can occur in children with 14q32 deletions and suggests surveillance for such tumors may be warranted.